Zoplar, a B2B full-stack healthcare startup that enhances the medical equipment procurement process for small and medium-sized hospitals in India, has raised $3.4 million in a Series A funding round led by Blume Ventures. Beenext, Saison Capital, Atrium Angels, Finfirst, and LogX also participated in the round.

With the newly raised funds, the startup plans to boost its operational capabilities by focusing on backward integration in the supply chain to build a service engineering team.

Founded in 2022 by Amit Sah and Umesh Sharma, the platform aims to address the struggles of MSME hospitals, including the complexities of identifying price-optimal products, managing multiple vendor relationships, ensuring high-quality after-sales service, and accessing financing solutions.

“We are thrilled to have the trust and support of our investors. This investment is not just financial backing—it’s a validation of our mission to make quality healthcare accessible through affordable and reliable medical technologies,” said Amit Sah and Umesh Sharma, Co-founder of Zoplar.

Since its launch, Zoplar has forged partnerships with approximately 300 hospitals, including prominent nephrology chains such as DCDC, leading with a 40 per cent rate of repeat customers.

“We invested in Zoplar because we believe in their vision and the potential impact they can have on the healthcare landscape in India. Their commitment to improving the procurement and after-sales service in medical equipment aligns with our focus on supporting ventures that drive societal change,” said lead investor Sajith Pai VC at Blume Ventures.

(with inputs from BL intern Shrabani Chakraborty)